- Home
- MORN vs QGEN Comparison
MORN vs QGEN Comparison
Compare MORN & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MORN | QGEN |
|---|---|---|
| Founded | 1984 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 10.2B |
| IPO Year | 2005 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MORN | QGEN |
|---|---|---|
| Price | $218.17 | $47.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $333.33 | $50.68 |
| AVG Volume (30 Days) | 296.7K | ★ 1.2M |
| Earning Date | 10-29-2025 | 11-04-2025 |
| Dividend Yield | 0.83% | ★ 3.21% |
| EPS Growth | 16.18 | ★ 331.20 |
| EPS | ★ 8.80 | 1.84 |
| Revenue | ★ $2,395,400,000.00 | $2,070,781,000.00 |
| Revenue This Year | $8.79 | $7.12 |
| Revenue Next Year | $7.52 | $6.13 |
| P/E Ratio | ★ $24.81 | $25.56 |
| Revenue Growth | ★ 7.76 | 5.32 |
| 52 Week Low | $202.89 | $37.63 |
| 52 Week High | $365.00 | $51.88 |
Technical Indicators
Market Signals| Indicator | MORN | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 54.56 | 55.46 |
| Support Level | $213.53 | $46.39 |
| Resistance Level | $219.62 | $48.13 |
| Average True Range (ATR) | 4.43 | 0.67 |
| MACD | 1.32 | 0.18 |
| Stochastic Oscillator | 89.38 | 68.53 |
Price Performance
Historical ComparisonAbout MORN Morningstar Inc.
Morningstar Inc is a provider of independent investment research to financial advisers, asset managers, and investors. The company focuses its operations on two core sectors: data and research. It offers data on investments such as mutual funds, stocks, exchange-traded funds, closed-end funds, separate accounts, and variable annuities. Further, the company tracks real-time market data of equity, derivative, currency exchanges, and other investments. In its research operation, Morningstar offers analyst research on passive and active mutual funds, alternative funds, and college saving plans. Morningstar's majority of the revenue is generated in the United States of America.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).